乐胖代购免代理版

{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,24]],"date-time":"2024-08-24T05:07:06Z","timestamp":1724476026369},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,2,11]],"date-time":"2015-02-11T00:00:00Z","timestamp":1423612800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cheminform"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13321-015-0053-y","type":"journal-article","created":{"date-parts":[[2015,2,10]],"date-time":"2015-02-10T13:01:22Z","timestamp":1423573282000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":57,"title":["Data-driven identification of structural alerts for mitigating the risk of drug-induced human liver injuries"],"prefix":"10.1186","volume":"7","author":[{"given":"Ruifeng","family":"Liu","sequence":"first","affiliation":[]},{"given":"Xueping","family":"Yu","sequence":"additional","affiliation":[]},{"given":"Anders","family":"Wallqvist","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2015,2,11]]},"reference":[{"key":"53_CR1","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/jat.2935","volume":"34","author":"V Ahuja","year":"2014","unstructured":"Ahuja V, Sharma S. Drug safety testing paradigm, current progress and future challenges: an overview. J Appl Toxicol. 2014;34:576\u201394.","journal-title":"J Appl Toxicol"},{"key":"53_CR2","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1001\/jama.1997.03540280045032","volume":"277","author":"DW Bates","year":"1997","unstructured":"Bates DW, Spell N, Cullen DJ, Burdick E, Laird N, Petersen LA, et al. The costs of adverse drug events in hospitalized patients. Adverse Drug Events Prevention Study Group. JAMA. 1997;277:307\u201311.","journal-title":"JAMA"},{"key":"53_CR3","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1001\/jama.279.15.1200","volume":"279","author":"J Lazarou","year":"1998","unstructured":"Lazarou J, Pomeranz BH, Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200\u20135.","journal-title":"JAMA"},{"key":"53_CR4","first-page":"27","volume-title":"Advances in bioactivation research. Vol. 8","author":"AS Kalgutkar","year":"2008","unstructured":"Kalgutkar AS. Role of bioactivation in idiosyncratic drug toxicity: structure-toxicity relationships. In: Elfarra AA, editor. Advances in bioactivation research. Vol. 8. New York: Springer; 2008. p. 27\u201355."},{"key":"53_CR5","first-page":"391","volume":"76","author":"T Lynch","year":"2007","unstructured":"Lynch T, Price A. The effect of cytochrome P450 metabolism on drug response, interactions, and adverse effects. Am Fam Physician. 2007;76:391\u20136.","journal-title":"Am Fam Physician"},{"key":"53_CR6","doi-asserted-by":"publisher","first-page":"E25","DOI":"10.1208\/ps040425","volume":"4","author":"K Ito","year":"2002","unstructured":"Ito K, Chiba K, Horikawa M, Ishigami M, Mizuno N, Aoki J, et al. Which concentration of the inhibitor should be used to predict in vivo drug interactions from in vitro data? AAPS PharmSci. 2002;4:E25.","journal-title":"AAPS PharmSci"},{"key":"53_CR7","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1056\/NEJMra021844","volume":"349","author":"WM Lee","year":"2003","unstructured":"Lee WM. Drug-induced hepatotoxicity. N Engl J Med. 2003;349:474\u201385.","journal-title":"N Engl J Med"},{"key":"53_CR8","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/nrd1750","volume":"4","author":"N Kaplowitz","year":"2005","unstructured":"Kaplowitz N. Idiosyncratic drug hepatotoxicity. Nat Rev Drug Discov. 2005;4:489\u201399.","journal-title":"Nat Rev Drug Discov"},{"key":"53_CR9","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.2174\/138161205774414510","volume":"11","author":"D Schuster","year":"2005","unstructured":"Schuster D, Laggner C, Langer T. Why drugs fail \u2013 a study on side effects in new chemical entities. Curr Pharm Des. 2005;11:3545\u201359.","journal-title":"Curr Pharm Des"},{"key":"53_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/978-1-4615-0667-6_4","volume":"500","author":"SD Nelson","year":"2001","unstructured":"Nelson SD. Structure toxicity relationships \u2013 how useful are they in predicting toxicities of new drugs? Adv Exp Med Biol. 2001;500:33\u201343.","journal-title":"Adv Exp Med Biol"},{"key":"53_CR11","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2174\/1389200054021799","volume":"6","author":"AS Kalgutkar","year":"2005","unstructured":"Kalgutkar AS, Gardner I, Obach RS, Shaffer CL, Callegari E, Henne KR, et al. A comprehensive listing of bioactivation pathways of organic functional groups. Curr Drug Metab. 2005;6:161\u2013225.","journal-title":"Curr Drug Metab"},{"key":"53_CR12","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1517\/17425255.2.6.923","volume":"2","author":"JC Erve","year":"2006","unstructured":"Erve JC. Chemical toxicology: reactive intermediates and their role in pharmacology and toxicology. Expert Opin Drug Metab Toxicol. 2006;2:923\u201346.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"53_CR13","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3109\/10408444.2013.811215","volume":"43","author":"M Hewitt","year":"2013","unstructured":"Hewitt M, Enoch SJ, Madden JC, Przybylak KR, Cronin MT. Hepatotoxicity: a scheme for generating chemical categories for read-across, structural alerts and insights into mechanism(s) of action. Crit Rev Toxicol. 2013;43:537\u201358.","journal-title":"Crit Rev Toxicol"},{"key":"53_CR14","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1021\/tx200168d","volume":"24","author":"AF Stepan","year":"2011","unstructured":"Stepan AF, Walker DP, Bauman J, Price DA, Baillie TA, Kalgutkar AS, et al. Structural alert\/reactive metabolite concept as applied in medicinal chemistry to mitigate the risk of idiosyncratic drug toxicity: a perspective based on the critical examination of trends in the top 200 drugs marketed in the United States. Chem Res Toxicol. 2011;24:1345\u2013410.","journal-title":"Chem Res Toxicol"},{"key":"53_CR15","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1080\/10408440590935620","volume":"35","author":"JL Walgren","year":"2005","unstructured":"Walgren JL, Mitchell MD, Thompson DC. Role of metabolism in drug-induced idiosyncratic hepatotoxicity. Crit Rev Toxicol. 2005;35:325\u201361.","journal-title":"Crit Rev Toxicol"},{"key":"53_CR16","doi-asserted-by":"crossref","first-page":"125ra131","DOI":"10.1126\/scitranslmed.3003377","volume":"4","author":"NP Tatonetti","year":"2012","unstructured":"Tatonetti NP, Ye PP, Daneshjou R, Altman RB. Data-driven prediction of drug effects and interactions. Sci Transl Med. 2012;4:125ra131.","journal-title":"Sci Transl Med"},{"key":"53_CR17","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1002\/hep.26175","volume":"57","author":"JH Hoofnagle","year":"2013","unstructured":"Hoofnagle JH, Serrano J, Knoben JE, Navarro VJ. LiverTox: a website on drug-induced liver injury. Hepatology. 2013;57:873\u20134.","journal-title":"Hepatology"},{"key":"53_CR18","unstructured":"SMiles ARbitrary Target Specification (SMARTS) notation \u2013 a language for describing molecular patterns [\n http:\/\/www.daylight.com\/dayhtml\/doc\/theory\/theory.smarts.html\n \n ]"},{"key":"53_CR19","doi-asserted-by":"publisher","first-page":"888","DOI":"10.2146\/ajhp100516","volume":"68","author":"H Khalili","year":"2011","unstructured":"Khalili H, Soudbakhsh A, Talasaz AH. Severe hepatotoxicity and probable hepatorenal syndrome associated with sulfadiazine. Am J Health Syst Pharm. 2011;68:888\u201392.","journal-title":"Am J Health Syst Pharm"},{"key":"53_CR20","doi-asserted-by":"publisher","first-page":"379","DOI":"10.2174\/1389200023337360","volume":"3","author":"AS Kalgutkar","year":"2002","unstructured":"Kalgutkar AS, Dalvie DK, O'Donnell JP, Taylor TJ, Sahakian DC. On the diversity of oxidative bioactivation reactions on nitrogen-containing xenobiotics. Curr Drug Metab. 2002;3:379\u2013424.","journal-title":"Curr Drug Metab"},{"key":"53_CR21","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1016\/j.bcp.2010.06.052","volume":"80","author":"TS Cruz","year":"2010","unstructured":"Cruz TS, Faria PA, Santana DP, Ferreira JC, Oliveira V, Nascimento OR, et al. On the mechanisms of phenothiazine-induced mitochondrial permeability transition: thiol oxidation, strict Ca2+ dependence, and cyt c release. Biochem Pharmacol. 2010;80:1284\u201395.","journal-title":"Biochem Pharmacol"},{"key":"53_CR22","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1517\/17425255.1.4.655","volume":"1","author":"K Chan","year":"2005","unstructured":"Chan K, Truong D, Shangari N, O'Brien PJ. Drug-induced mitochondrial toxicity. Expert Opin Drug Metab Toxicol. 2005;1:655\u201369.","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"53_CR23","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.tiv.2007.01.011","volume":"21","author":"S Nadanaciva","year":"2007","unstructured":"Nadanaciva S, Bernal A, Aggeler R, Capaldi R, Will Y. Target identification of drug induced mitochondrial toxicity using immunocapture based OXPHOS activity assays. Toxicol In Vitro. 2007;21:902\u201311.","journal-title":"Toxicol In Vitro"},{"key":"53_CR24","doi-asserted-by":"publisher","first-page":"55","DOI":"10.2165\/00002018-200932010-00005","volume":"32","author":"RJ Fontana","year":"2009","unstructured":"Fontana RJ, Watkins PB, Bonkovsky HL, Chalasani N, Davern T, Serrano J, et al. Drug-Induced Liver Injury Network (DILIN) prospective study: rationale, design and conduct. Drug Saf. 2009;32:55\u201368.","journal-title":"Drug Saf"},{"key":"53_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/0471200611","volume-title":"Elements of information theory","author":"TM Cover","year":"1991","unstructured":"Cover TM, Thomas JA. Elements of information theory. New York: John Wiley & Sons; 1991."}],"container-title":["Journal of Cheminformatics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-015-0053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13321-015-0053-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-015-0053-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13321-015-0053-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T14:00:03Z","timestamp":1561384803000},"score":1,"resource":{"primary":{"URL":"https:\/\/jcheminf.biomedcentral.com\/articles\/10.1186\/s13321-015-0053-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,11]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["53"],"URL":"https:\/\/doi.org\/10.1186\/s13321-015-0053-y","relation":{},"ISSN":["1758-2946"],"issn-type":[{"value":"1758-2946","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,11]]},"assertion":[{"value":"9 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"4"}}